Trying to predict the future for people with diabetes: A tough but important task

被引：15

作者：

Engelgau, MM ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2005年 / 143卷 / 04期

关键词：

D O I：

10.7326/0003-4819-143-4-200508160-00011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The article by Eddy and colleagues describes a novel approach to modeling the costs and outcomes of health interventions. As applied to programs to alter lifestyle to prevent diabetes in patients with impaired glucose tolerance, the model's predictions are similar in most respects to previous work but differ about cost-effectiveness. This difference leads the authors to diametrically opposed conclusions about whether health plans should offer programs to modify lifestyle.

引用

页码：301 / 302

页数：2

共 14 条

[1] Modeling complex medical decision problems with the Archimedes model [J].

Brandeau, ML .

ANNALS OF INTERNAL MEDICINE, 2005, 143 (04) :303-304

[2] Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].

Colhoun, HM ;

Betteridge, DJ ;

Durrington, PN ;

Hitman, GA ;

Neil, HAW ;

Livingstone, SJ ;

Thomason, MJ ;

Mackness, MI ;

Charlton-Menys, V ;

Fuller, JH .

LANCET, 2004, 364 (9435) :685-696

[3] Archimedes - A trial-validated model of diabetes [J].

Eddy, DM ;

Schlessinger, L .

DIABETES CARE, 2003, 26 (11) :3093-3101

[4] Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes [J].

Eddy, DM ;

Schlessinger, L ;

Kahn, R .

ANNALS OF INTERNAL MEDICINE, 2005, 143 (04) :251-264

[5] Mode of onset of type 2 diabetes from normal or impaired glucose tolerance [J].

Ferrannini, E ;

Nannipieri, M ;

Williams, K ;

Gonzales, C ;

Haffner, SM ;

Stern, MP .

DIABETES, 2004, 53 (01) :160-165

[6] ONSET OF NIDDM OCCURS AT LEAST 4-7 YR BEFORE CLINICAL-DIAGNOSIS [J].

HARRIS, MI ;

KLEIN, R ;

WELBORN, TA ;

KNUIMAN, MW .

DIABETES CARE, 1992, 15 (07) :815-819

[7] The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance [J].

Herman, WH ;

Hoerger, TJ ;

Brandle, M ;

Hicks, K ;

Sorensen, S ;

Zhang, P ;

Hamman, RF ;

Ackermann, RT ;

Engelgau, MM ;

Ratner, RE .

ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) :323-332

[8]

Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512

[9]

LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473

[10]

Neumann PJ, 2004, AM J MANAG CARE, V10, P308

← 1 2 →